ONCOTYPE DX MULTIVARIATE INDEX

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2011-05-27 for ONCOTYPE DX MULTIVARIATE INDEX manufactured by Genomic Health.

Event Text Entries

[2008175] Estrogen receptor performed by rt-pcr and reported on the oncotype dx test/device - (b)(6) was negative on this pt's breast cancer. However, the estrogen receptor performed on the very same tissue block as the oncotype dx test was moderately positive, with a semiquantitive histoscore of 115/300. The oncotype test in this instance is a false negative result, that could have resulted in a disastrous decision not to treat this pt with hormonal therapy for her breast cancer. The immunohistochemistry test result was performed using an fda cleared kit.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5020810
MDR Report Key2113220
Date Received2011-05-27
Date of Report2011-05-27
Date of Event2011-05-06
Date Added to Maude2011-06-10
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameONCOTYPE DX MULTIVARIATE INDEX
Generic NameONCOTYPE DX
Product CodeNPQ
Date Received2011-05-27
Device AvailabilityY
Device Sequence No1
Device Event Key0
ManufacturerGENOMIC HEALTH
Manufacturer AddressREDWOOD CITY CA US


Patients

Patient NumberTreatmentOutcomeDate
10 2011-05-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.